The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


SKP SKYEPHARMA PLC ORD 100P

SKYEPHARMA  Currency  GBX  Premium Equity Commercial Companies



 Page 1 of 4

| 1 | 2 | 3 | 4 | Next

Time/Date Code Headline Source Impact
07:00 17-Apr-2014 SKP Result of Placing & Open Offer RNS 0.00% 
10:00 16-Apr-2014 SKP Holding(s) in Company RNS +3.79% Up
10:19 15-Apr-2014 SKP Holding(s) in Company RNS -0.48% Down
15:09 04-Apr-2014 SKP Holding(s) in Company RNS -4.17% Down
17:03 03-Apr-2014 SKP Holding(s) in Company RNS -3.33% Down
11:51 03-Apr-2014 SKP Director/PDMR Shareholding RNS -3.33% Down
11:50 03-Apr-2014 SKP Director/PDMR Shareholding RNS -3.33% Down
16:58 01-Apr-2014 SKP Annual Financial Report RNS +1.49% Up
07:45 31-Mar-2014 SKP Proposed Placing and Open Offer to Raise 112m RNS +8.33% Up
07:00 31-Mar-2014 SKP Final Results RNS +8.33% Up
07:00 26-Mar-2014 SKP Notice of Results RNS +15.54% Up
16:52 21-Mar-2014 SKP Holding(s) in Company RNS +0.79% Up
14:44 06-Mar-2014 SKP Director Declaration RNS +1.22% Up
07:00 05-Mar-2014 SKP Board Changes RNS +1.87% Up
09:47 04-Mar-2014 SKP Holding(s) in Company RNS +2.19% Up
15:38 03-Mar-2014 SKP Holding(s) in Company RNS +2.46% Up
07:02 28-Feb-2014 SKP Board Change RNS +2.26% Up
14:53 21-Feb-2014 SKP Anoro Receives Positive Opinion from CHMP RNS +2.91% Up
17:59 10-Feb-2014 SKP Holding(s) in Company RNS +17.22% Up
07:00 10-Feb-2014 SKP flutiform launched in France RNS +17.22% Up

 Page 1 of 4

| 1 | 2 | 3 | 4 | Next

Price changes are calculated on the basis of the following formula: [avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s
price over the time period analysed by the News Analysis tool.


SKYEPHARMA share - news analysis

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds